LSI's Select Alumni (Return) Presenters Announced Soon!
LSI Europe '22
Confirmed Presenting Companies
Aortyx is developing a solution for the treatment of aortic dissection. The company is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being.
Designer and manufacturer of medical simulation products. Core range of simulators includes ‘take-home’ laparoscopic simulators and a range of institutional based laparoscopic simulators. The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.
Paragate Medical is developing an implantable peritoneal ultrafiltration device that functions as a mechanical bypass too the kidneys and maintain fluid balance in patients with kidney or chronic heart failure.
Onera Health develops diagnostic and monitoring solutions to help people with sleep-related ailments. The company's Onera STS wearable sleep system collects comprehensive sleep data which allows providers to optimize patient care and reduce costs.
Endoron is developing a long-lasting solution for the treatment of abdominal aortic aneurysm (AAA). The company's Aortoseal system uses a smart stapling system that penetrates the aortic wall and stent graft to secure the graft in place in a variety of anatomies.
Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.
BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
Andrew A. Dahl, Founder & Chairman BioMEMS Diagnostics
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds. The wound management platform consists of a nanotechnology wound gel dressing formulation (HemastylRx) and Gen-Ray, a device to apply mild-heating to the wound to accelerate absorption and stimulate the healing process.
Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.
Cold cap therapy is a commonly used solution to prevent hair loss in patients undergoing chemotherapy. Cooler Heads is developing a novel cold cap system for cancer patients that has been designed to be easier to use and more affordable than existing solutions.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Locate Bio specializes in the development of orthobiologics for orthopedic surgery. The company's orthobiologic products leverage Locate Bio's expertise in programmed drug release and instructive tissue scaffolds to enhance the tissue repair process.
SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science.
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
Gradient Denervation Technologies is using thermal ablation to reduce pulmonary pressure in patients with pulmonary hypertension. The technology will target the nerves responsible for the hyperactivity of the pulmonary artery nerves to produce a long-term reduction in pulmonary pressure.
Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy.
HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.
Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.
Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere. Our patented Q-LAAD technology allows us to develop diagnostics tests without the tradeoff between speed, accuracy, and ease of use inherent in legacy diagnostic testing technologies. Join us to learn more about the diagnostic testing revolution.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
Manny Villafana, Founder of St. Jude Medical, ATS, Cardiac Pacemakers Medical 21
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues.
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.